The BPC-157 sequence is a partial fragment of a larger gastric protein, Body Protection Compound, first characterised in published research in the 1990s
Stable for years under reasonable conditions
BPC-157 has demonstrated promise in a wide range of medical applications, from promoting muscle and tendon healing to potentially aiding in the treatment of gastrointestinal issues , such as ulcers and inflammatory bowel disease
In tumours, hypoxia is observed in cancer cells that reside more than 70150 m away from a perfused blood vessel
A recent randomized controlled trial indicated that vitamin B12 supplementation significantly decreased serum levels of homocysteine compared to placebo, while no significant difference was revealed in between-group comparisons for fasting blood glucose, malondialdehyde, and liver steatosis (55)